Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/febs.15696

http://scihub22266oqcxt.onion/10.1111/febs.15696
suck pdf from google scholar
33400393!ä!33400393

suck abstract from ncbi


Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33400393      FEBS+J 2021 ; 288 (17): 5089-5121
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Overview of antiviral drug candidates targeting coronaviral 3C-like main proteases #MMPMID33400393
  • Chen CC; Yu X; Kuo CJ; Min J; Chen S; Ma L; Liu K; Guo RT
  • FEBS J 2021[Sep]; 288 (17): 5089-5121 PMID33400393show ga
  • Coronaviruses (CoVs) are positive single-stranded RNA viruses that cause severe respiratory syndromes in humans, including severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS). Coronavirus disease 2019 (COVID-19) caused by a novel severe acute respiratory syndrome CoV (SARS-CoV-2) at the end of 2019 became a global pandemic. The 3C-like cysteine protease (3CLpro) processes viral polyproteins to yield mature non-structural proteins, thus playing an important role in the CoV life cycle, and therefore is considered as a prominent target for antiviral drugs. To date, many 3CLpro inhibitors have been reported, and their molecular mechanisms have been illustrated. Here, we briefly introduce the structural features of 3CLpro of the human-related SARS-CoV, MERS-CoV and SARS-CoV-2, and explore the potency and mechanism of their cognate inhibitors. This information will shed light on the development and optimization of CoV 3CLpro inhibitors, which may benefit the further designation of therapeutic strategies for treating CoV diseases.
  • |*COVID-19 Drug Treatment[MESH]
  • |Antiviral Agents/chemistry/therapeutic use[MESH]
  • |COVID-19/enzymology/virology[MESH]
  • |Coronavirus 3C Proteases/antagonists & inhibitors/chemistry/*genetics[MESH]
  • |Humans[MESH]
  • |Molecular Targeted Therapy[MESH]
  • |Pandemics[MESH]
  • |Protease Inhibitors/chemistry/*therapeutic use[MESH]
  • |SARS-CoV-2/*drug effects/enzymology/pathogenicity[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box